Simulation Studies to Assess Stopping Rules in Clinical Trials
Simulation Studies to Assess Stopping Rules in Clinical Trials Using Simulation Studies to Evaluate Stopping Rules in Clinical Trials Introduction: Why Simulations Are Essential Stopping rules for interim analyses must balance statistical rigor, ethical oversight, and regulatory compliance. Because analytical solutions are not always sufficient to predict trial behavior under complex scenarios, sponsors use simulation…
Read More “Simulation Studies to Assess Stopping Rules in Clinical Trials” »